Pfizer, Inc. (PFE)
NASDAQ • Healthcare
January 21, 2026 at 21:00 UTC
Name
CEO
Website
Industry
Year Founded
Employees
Pfizer, Inc. is a pharmaceutical company that discovers, develops, and supplies medicines and vaccines used in clinical practice worldwide. The operating model links science with delivery: research feeds trials, approvals lead to scaled production, and medical education supports appropriate use. Manufacturing and quality systems favor continuity, so once therapies enter practice, supply stays steady. Field teams focus on safety, labeling clarity, and guidance that fits real workflows in hospitals and clinics. Access programs and country teams adapt to local rules while holding to common standards. The goal is simple and long-term: turn evidence into dependable options that clinicians can trust and patients can live with. Within healthcare, Pfizer’s role is to make new treatments feel workable in daily care.
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Pfizer, Inc.'s Technical Indicators Summary
Pfizer’s current price sits comfortably above its short and long-term moving averages, reflecting a solid upward trend supported by multiple buy signals from both the 10- and 200-day averages. Momentum indicators such as the CCI and MACD confirm positive momentum, although the RSI and Williams %R suggest a more cautious hold stance. The ADX indicates a moderate trend strength, while the average true range points to stable volatility without significant spikes. Despite this bullish environment, the On-Balance Volume shows a sell signal, highlighting some divergence in volume trends. Overall, the technical picture for Pfizer remains constructive, with price action supported by strong moving averages and momentum indicators.
| Indicator | Value |
|---|---|
RSI (14) | 55.28 |
Stochastic %K (14, 3, 3) | 74.29 |
CCI (20) | 153.37 |
WPR (14) | -30.51 |
Momentum (10) | 0.47 |
MFI | 60.15 |
MACD Level (12, 26) | 0.08 |
Bollinger Bands | $24.71 - $25.76 |
ATR (14) | $0.49 (1.93%) |
ADX (14) | 20.18 |
OBV | 709,593,300 |
Simple Moving Averages | $24.47 - $25.42(5 indicators) |
Exponential Moving Averages | $24.92 - $25.46(5 indicators) |
Get premium market insights delivered directly to your inbox.
The bell brought only a slight negative bias, with PFE edging -0.196% lower to open at 25.47 versus 25.52. The sector opens with a modest gain of 1.24%, offering a light tailwind for PFE. Pfizer stock dips slightly amid sector gains as the company invests in oncology and GLP-1 drugs to boost growth.
Price Change
from $25.52 close
+$0
Trading Volume
Below avg (50.1M)
8.3M
vs S&P 500 Today
Underperforming Market
-0.86%
52-Week Position
Upper range
67.9%
Updated: January 21, 2026 at 15:45 UTC
Wall St Mixed as Jobs Data, Oil Hit Sentiment
December 17, 2025
Dow Hits Record High Amid Shutdown Optimism, Tech Stocks Slide
November 12, 2025
Palantir Faces Correction Amid Strong AI Growth and Market Skepticism
November 7, 2025